In particular, S100B levels in cerebrospinal fluid, together with other AD biomarkers such as amyloid β and phosphorylated τ, have recently been shown to have distinctive associations with higher gray matter volumes and increased glucose metabolism in key Alzheimer-related regions [18]. This evidence concerns the gene S100B and Alzheimer disease.